Second quarter 2018


Second quarter 2018 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

We look forward to entering a new growth phase led by our increasing focus on Speciality Care and our leadership positions in Emerging Markets and Vaccines

Olivier Brandicourt

Chief Executive Officer



Download the audio mp3 file


Clinical trials appendix

Press Release - July 31, 2018: Q2 2018 Performance Positions Sanofi for New Growth Phase

Q2 2018 net sales by GBU, franchise, geographic region and product